跳到主要內容區塊 :::

研究成果

 

  • 每週定期舉行期論文討論及病例討論
  • 於國內外醫學雜誌發表論文,如下:
    1. Lin, CK* “Pernicious anemia that disappeared” Hosp. Practic. 1987;22;39.
    2. Peng HW, Lin CK, et at; “Detection of alpha thalassemia in patients with microcytic hypochromic anemia or microcytosis by restriction endounclease mapping”. Chin Med J. (Taipei). 1988; 41; 25-30.
    3. Lin CK*, Huang MJ, Hsu Ho; “The role of red blood cell distribution width in the differential diagnosis of microcytic anemia”. Kaosiung J Med Scien. 1988; 4;491-4.
    4. Wang Sy, Ho CK, Chen LY, Lin OK, et at; “The effect of lipopolysaccharide on the production of GM-EA, GM-CSA and PGE, by human monocyte-derived lipid-containing macrophages. Exp Hematol. 1988; 16; 349-54.
    5. Wang Sy, Wang GS, Lin OK; “Long-term bone marrow culture and the in vitro hematopoietic microenviroment. The optima! conditions for hematopoiesis in long-term bone marrow culture”. J. Formosan Med Assoc. 1988; 87:728-37.
    6. Chang TT, Lin CK*, et at; False blood cell indices caused by cryoglocrbulin and cold hemagglutinin”. Chin Med J. (Taipei) 1988;42;169-74.
    7. Lin CK*, “Fine needle aspiration biopsy cytology of head and neck masses; a personal experience in the Republic of China”. Chin Med J (Taipei) 1988;42;255-60.
    8. Lin OK*, Hsu HO, Huang MJ; “Assay of discriminant functions and new proposals in thalassemic evaluation”. Chin Med J (Taipei) 1988; 42;333-8.
    9. Lin TO, Lin CK*, Lee JY, et at; “X-linked dyskeratosis congenita with aplastic anemia— genetic and hematologic studies”. Chin Med J. (Taipei) 1989;43:57-62.
    10. Chen LY, Wang SY, Lin OK, et at; “Release of colony-stimulating activity by resting and activated monocytes, T-cells and B-cells”. Chin Med J (Taipei) 1989; 43; 277-84.
    11. Lin CK* & Gau JP; “Aplastic anemia is not aetiologicall associated with hepatitis B in Taiwan”. European J Haematol. 1989;42; 505. (letter).
    12. Peng HW, Choo KB, Ho CH, Yen MS, Liung WY, Lin CK, et al; “Arrangements of alpha?globin gene cluster in Taiwan”. Acta Haemat. 1989; 82;64-8.
    13. Lin CK* et al; “Iron overload in untransfused patients with hemoglobin H disease”. Acta Haemat. 1990; 83;137-9.
    14. Hsu HO, Lin CK, et at; “Combined cold- and warm-antibody autoimmune hemolytic anemia — review of the literature and a case report”. Kaohsiung J Med Sci. 1989;5; 350-6.
    15. Lin CK*, et al; “Aplastic anemia in Taiwan and its etiological factors”. J Formosa Med Asso.1989;88; 1113-7.
    16. Lin CK*, et al; “Efficacy of a modified improved technique for detecting red cell haemoglobin H inclusions”. Clin lab Haemat. 1990; 12; 409-415.
    17. Hsu HO, Lin OK*; et a!; “Iron overload in Chinese patients with hemoglobin H disease”. Am J Hematol. 1990; 34; 287-290.
    18. Hsu HC, Wang CC, Peng HW, Ho OH & Lin OK, “Hemoglobin H disease — ten year’s experience in VGH-Taipei”. Chin Med J. (Taipei) 1990; 45; 34-38.
    19. Lee JY, Lin CK*, et al, “Fine needle aspiration biopsy cytology of superficia lymph nodes”. Chin Med J (Taipei) 1989; 44; 305-12.
    20. Wang SY, LI YM, Wang RC, Lin OK et al; “Detection of the target progenitor cells of granulomonopoietic enhancing activity”. Blood 1990; 76; 495-500.
    21. Wang IS, Ho OH, Lin CK*, “Chronic neutrophilic leukemia. Report of a case and review of the literature”. Chin Med J. (Taipei) 1990; 46; 109-112.
    22. Lin JS, Lin CK*, et al, “Myelodysplastic syndrome; a study of prognostic factors”. J. Form osan Med Assoc 1991 ;90; 232-9.
    23. Hsu HO, Tsay SH, Ohau WK, Chow MP, Ho CH, Yung Oh, Lin OK; “Iron overload disorder — diseases often silent but no invisible in Taiwan”. Chin Med J (Taipei) 1990; 46; 331-6.
    24. Wang SY, Ohen LY, Wang SJ, Lin OK, et al; ‘Growth inhibition and differentiation in HL-60 cells induced by 1 ,25j-odihydroxyvitamin D and tumor necrosis factor”. Exp Hematol. 1991; 19; 1025-30.
    25. Gau JP, Lin OK*, et al, “The lack of antiplatelet effect of crude extracts from Ganoderma Lucidum on HIV-positive hemophiliacs”. AM J Chin Med 1990;18; 175-179.
    26. Chow MP, Hsu HO, Yung Oh, Chau WK Peng HW, Tsay SH, Tse E & Lin OK, “Hemoglobin H disease complicated iron overload and HLA expression in Chinese”. Chin J Microbiol & Immunology. 1990; 23;248-52.
    27. Lin CK*, et al; “Myelodysplastic syndromes; a study of internuclear bridging and invitro growth patterns”. J Med Sciences 11(1); 13-24, 1991.
    28. Chow MP, Yung OH, Hu HY, Tzeng JL, Lin WM, & Lin OK; “Plateletcrossmatching with lymphocytotoxicity test; an effective method in alloimmunized Chinese patients”. Transfusion 1991; 31; 595-9.
    29. Lin CK* et al; “Alpha-thalassemia traits are common in Taiwanese population usefulness of a modified hemoglobin H preparation of prevalence studies”. J. Lab Olin Med. 1991; 118; 599-603.
    30. Lin CK*, et al, “Comparison of two screening methods, modified Hb H preparation and the osmotic fragility test, for alpha-thalassemic traits on the basis of gene mapping”. J Clin Lab analysis. 1991; 5; 392-5.
    31. Wang SY, Hsu ML, Su CY, Lin Ok, et at; “In vivo stimulation of myelopoiesis in cyclophosphamide-treated mice by purified human GM-CSF”. Chin Med J (Taipei) 1991;48; 171-6.
    32. Chow MP, Lin CK, et ar; “H IV, Hay and HCV seroconversion in Hemophiliacs”. Chin J Microbiol & Immunology. 1991 ;24; 339-44.
    33. Liu NH, Lin CK*, et at; “The influence of histological subtype on survival of intermediate grade non-Hodgkin’s lymphoma”. J Chin Oncot Society. 1991; 7; (3) 1-10.
    34. Chow MP, Yung OH, Hu HY, Tzeng JL, Lin JS, Lin WM & Lin OK; “HLA antibodies — the cause of platelet alloimmunization in Chinese”. Am J Hematol. 1992; 39; 15-19.
    35. Lin CK*, et at; “Iron absorption is increased in HB H diseases”. (letter) Am J Hematol 1992;40; 74-5.
    36. Lin CK*, et at; “Iron absorption in Hb H disease’. Chin Med J (Taipei) 1992; 49; 76-80.
    37. Chien CC, Lin CK*, et at; ‘Does Hakka ethnic group have higher incidence of thalasseniia traits in Taiwanese population?’ Chin Med J (Taipei). 1992;50; 288-92
    38. Lin CK*, et al; Comparison of hemoglobin and red cell distribution width in differential diagnosis of microcytic anemia’. Arch PatholLab Med. 1992; 116; 1030-2.
    39. Chow MP, Lin OK, et al; ‘Steroid responded red cell aplasia patient complicated with acute hepatitis”. J. Med Sd 1992; 12; 285-8.
    40. Chow MP, Lin JS, Lin CK, et al; “HLA antigen and antibody association in plateletalloirnmunized patients. Chin Med. J (Taipei), 1993; 51; 329-32.
    41. Chow MP, Chau WK, Liu LS, Yung CH & Lin CK; “Peripheral blood mononuclear cell collection and processing—. J Med Sci. 1993; 13; 285-90.
    42. Lin CK*, Hsu HC, Chau WK, Jiang ML & Chiu CE; “Reticulocyte with maturation fractions in pancytopenic evaluation by fully automated counter”. J Olin Lab analysis 1993; 7; 371-5.
    43. Hsu HC, Tsai WH, Chen LY, Kuo BI, Lin CK, Wang SY: Macrophage inflammatory protein Ia overproduction in severe aplastic anemia. Blood; 1993; 82(10): 90a.
    44. Lin CK*, Chiu OF, Kuc IT, Un EM, Jiang ML, Chow MP; “Do the reticulocyte maturation fractions and bore marrow reticulocyte count further help the classification of anemias?” Chin Med J (Taipei) 1994;53; 270-5.
    45. Chiu CF, Chow KC, Lin FM, Lin CK et at: Expression of DNA Topoisomerase II alpha and multidrug resistance p-glycoprotein in acute leukemia. Chin Med. J (Taipei).1997;60; 184-90.
    46. Ching-Shan Huang, Yung-Chuan Sung, May-Jen Huang, Chung-Shi Yang, Wei-Shang Shei, and Tang K. Tang. Content of Reduced Glutathione and Consequences in Recipients of Glucose-6-Phosphate Dehydrogenase Deficient Red Blood Cells. American Journal of Hematology 57:187-192 (1998)
    47. Liu HT. Hsu C. Chen CL. Chiang IP. Chen LT. Chen YC. Cheng AL. Chemotherapy alone versus surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach. American Journal of Hematology. 64(3):175-9, 2000 Jul. 10861812
    48. Hsu C. Chen CL. Chen LT. Liu HT. Chen YC. Jan CM. Liu CS. Cheng AL. Comparison of MALT and non-MALT primary large cell lymphoma of the stomach: does histologic evidence of MALT affect chemotherapy response?. Cancer. 91(1):49-56, 2001 Jan 1. 11148559
    49. Chung-Huo Chen, Yung-Chuan Sung, Chih-Hui Chin and Paul H. Chen. Transesophageal Findings of Metastatic Cardiac Lymphoma complicated with Superior Vena Cava Syndrome. Acta Cardiologica Sinica, 2003;19:39-42
    50. Yung-Chih Lai, Cheng-Yen Shih, Chin-Ming Jeng, Sien-Sing Yang, Jui-Ting Hu, Yung-Chuan Sung, Hang- Ting Liu, Shaw-Min Hou, Chi-Hwa Wu, Tzen-Kwan Chen. Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with tumor thrombosis of the portal vein. World Journal of Gastroenterology 2003;9(12):2666-2670
    51. Yung-Chuan Sung, Chung-Huo Chen, Chih-Yu Hsu. Cardiac Tumor as the Sole Manifestation of Relapse of Non-Hodgkin’s Lymphoma: A Case Report. J. Intern Med Taiwan 2004; 15:81-85
    52. Yeur-Hur Lai, Shu-Liu Guo, Francis Keefe, Shin-Ling Tsai, Chih-Cheng Chien, Yung-Chuan Sung, Mei-ling Chen. Effects of brief pain education on hospitalized cancer patients with moderate to severe pain. Supportive Care in Cancer 2004; 12(9): 645-652
    53. Chi-Cheng Huang, Heng-Hui Lien, Ching-Shui Huang, Yung-Chuan Sung. Surgical Resection Combined with Systemic Imatinib therapy for the Treatment of Advanced Gastrointestinal Stromal Tumor. Formos. J Surg. 2004; 37:218-224
    54. Hsing-I Huang, Chih-Cheng Chien, Shih-Hsin Tu, Yung-Chuan Sung, Chin-Long Lin and Kai-Mo Chen. The Expression of MAGE Genes in Human Breast Carcinoma in Taiwan. FJJM 2004; 2(3) 241-247
    55. 李紋瑜, 鄭慶明,徐志育,宋詠娟,黃世鴻,王永成,孔慶惠,吳昭瑩中華放射線醫學雜誌29:2; 2004,04: 99-103. Intra-abdominal Desmoplastic Small Round Cell Tumor: CT and MR Findings: A Case Report
    56. Shaw-Min Hou, Pa-Chun Wang, Yung-Chuan Sung, Henry Hsin-Chung Lee, Han-Tin Liu, Ya-Hui Chen. Comparison of outcomes and survivals for two central venous access port systems. Journal of Surgical Oncology 2005; 91:61-66
    57. Ying-Ih Shih , Po-Min Chen, Paul Chih-Hsueh Chen, Liang-Tsai Hsiao Lymphoma Presenting as Sister Mary Joseph's Nodule Sparing Intra-Abdominal Involvement International Journal of Hematology. 2006 83:194
    58. Chia-Li Cheng, Hung-Cheng Lin Jeffery Wu, Chih-Yi Liu, Yung-Chuan Sung. Submandibular Lymphoma-Case Report. Chin Dent J 2006 June, 25 (2):124-128.
    59. Chi-Cheng Huang, Heng-Hui Lien, Yung-Chuan Sung, Han-Ting Liu and Wei-Chu Chie*. Quality of life of patients with gastric cancer in Taiwan: Validation and clinical application of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-STO22; Psycho-Oncology 2007 Oct;16 (10): 945-9
    60. Chien-Chun Yang, Jeffery Wu, Yung-Chuan Sung, Yang-Yang Huang. The Assessment of Preoperative Autologous Blood Donation Program for Oral and Maxillofacial Surgery. J Biomed Lab Sci 2007 Vol 19 N0 4 117-122
    61. Suzun Shaw, Yung-Chuan Sung, Ching-hui Huang, Min-Yen Shi, Han-Tin Liu, Pei-Chieh Yu, Ching-Jung Wu. Adjuvant Chemoradiation for Surgical Reseced Gastric Cancer Patients: CGH Experience. Therapeutic Radiology and Oncology Vol. 15, No 4, p. 279-287, December 2008
    62. Chung-King Lin, Yung-Chuan Sung. Newly diagnosed multiple myeloma in Taiwan: the evolution of therapy, stem cell transplantation and new treatment agents. Hematol Oncol Stem Cell Ther 2(3); 2009:385-393
    63. Yung-Chuan Sung, Henry Hsin-Chung Lee, Ying-Yih Shih. Molecular Markers in Colorectal Cancer. Clinical Molecular Medicine 1(2): 19-27, 2009
    64. Shih-Chang Chang, Ming-Hung Shen, Henry Hsin-Chung Lee, Yung-Chuan Sung. Gastrointestinal Perforation in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab (Avastin)—Three Cases Report. J Soc Colon Rectal Surgeon (Taiwan) 22:2; 2011, 06, 29-44
    65. Hui-Wen Liu, Henery Hsin-Chung Lee, Chi-Lan Kao, Ching-Ping Tseng, Han-Tin Liu, Chung-King Lin, Yung-Chuan Sung. Prevention of Chemotherapy Prescription Errors with Hematology/Oncology Computerized Physician Order Entry system—Experience from a Medical Center. J Cancer Res. Pract. 27(3), 100-112, 2011
    66. Ling-Ping Chen. Diffuse large B cell lymphomas deriving from gastrointestinal tract have superior survival outcomes compared to those from non-gastrointestinal origin: a single institution experience. Fu-Jen Journal of Medicine. 10(1) : 1-12, 2012
    67. Ling-Ping Chen. First-Line CEOP with or without Rituximab for Treating Diffuse Large B Cell Lymphomas: Predictive Value of the Absolute Lymphocyte Count. Fu-Jen Journal of Medicine. 10(3): 129-142, 2012.
    68. Feng-Hsiang Chung, Yun-Ru Chiang, Ai-Lun Tseng, Yung-Chuan Sung, Jean Lu, Min-Chang Huang, Nianhan Ma, Hoong-Chien Lee. Functional Modile Connectivity Map (FMCM): A Framework for Searching Repurposed Drug Compounds for Systems Treatment of Cancer and an Application to Colorectal Adenocarcinoma. PLOS ONE 9 ( 1 ): 2014: e86299
    69. Chung-King Lin, Ling-Ping Chen, Hsiu-Lin Chang, Yung-Chuan Sung. Underestimation of the coexistence of iron deficiencies and thalassemia minors: a single institution experience in Taiwan. Kaohsiung Journal of Medical Sciences (2014) 30, 409-414
    70. Tzeon-Jye Chiou, Yi-Fang Chuang, Ming_Chung Wang, Chen-Wei Kao, Hsuan-Yu Lin, Tsai-Yun Chen, Erh-Jung Hsueh, Yii-Jeng Lan, Yung-Chuan Sung, Sheny-Fey Lin, Li-Yuan Bai, Caleb G Chen. Eltrobopag Enhances Platelet Adhesion by Upregulating the Expression of Glycoprotein VI in Platelet with Chronic Immune Thrombocytopenic Purpura. Transl. Res. Epub 2015. Sep. 30
    71. Hui-Wen Liu, Henery Hsin-Chung Lee, Yung-Chuan Sung. Survival of Resectable Stage II Colon Cancer Patients: Focus on Chemotherapy-Exaperience from a Single Institution. J. Cancer Res. Pract. 2(4), 293-300, 2015.
    72. Siew Tzuh Tang, DNsca; Tsang-Wu Liu, MDb; Fur-Hsing Wen, PhDc; Chiun Hsu, MD, PhDd; Yi-Heng Chang, MDe; Cheng-Shying Chang, MDf; Yung-Chuan Sung, MDg; Cheng-I Hsieh, MDh; Shou-Yi Chang, MDi; Li Ni Liu, PhDj; and Ming-Chu Chiang, MSk. A Decade of Changes in Preferences for Life-Sustainging Treatment Among Terminally Ill Patients with Cancer. JNCCN. 13 (12), 1510-1518, 2015
    73. Tzwon-Jye Chiou, Yi-Fang Chang, Ming-Chung Wang, Chen-Wei Kao, Hsuan-Yu Ling, Tsai-Yun Chen, Erh-Jung Hsueh, Yii-Jenq Lan, Yung-Chuan Sung, Sheng-Feng Lin, Li-Yuan Bai, and Caleb G. Chen. Eltrombopeg enhances platelet adhesion by upregulating the expression of glycoprotein VI in patients with chronic immune thrombocytopenic purpura. Trans. Res. 166 (6) 750-761, 2015
    74. Yung-Sung Yeh, Hsiang-Lin Tsai, Ching-Wen Huang, Jui-Ho Wang, Yi-Wen Lin, Hsiu-Chihih Tang, Yung-Chuan Sung, Chang-Chieh Wu, Chien-Yu Lu, Jaw-Yuan Wang. Prospective analysis of UGT1A1 promotor polymorphism for irinotecan dose escalation in metastatic colorectal cancer patients treated with bevacizumab plus FOLFIRI as the first-line setting: study protocol for a randomized controlled trisl. BioMed Central (2016) 17:46 DOI 10.1186/s1 3063-016-1153-3
    75. Yung-Chuan Sung, Ling-Ping Chen, Ying-Yih Shih, Yuan-Hsin Chang, Hui-Wen Liu. Hematologic Manifestation of Cancer Bone Marrow Metastasis—a Retrospective Review of a Medical Center in Taiwan. Fu- Jen Journal of Medicine. 2016, 14(4):185-196
    76. Yung-Sung Yeh, Hsiang-Lin Tsai, Ching-Wen Huang, Po-Li Wei, Yung-Chuan Sung, Hsiu-Chih Tang, Jaw-Yuan Wang. Maintenance tegafur-uracil versus observation following an adjuvant oxalipaltin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized control trial. Trials (2017) 18:191. DOI 10.1186/s13063-017-1904-9
    77. Wen-Chi Shen, Jen-Shi Chen, Yu-Yun Shao, Kuan-Der Lee, Tzeon-Jje Chiou, Yung-Chuan Sung, Kun-Ming Rau, Chia-Jui Yen, Yu-Min Liao, Ta-Chih Liu, Ming-Fang Wu, Ming-Yang Lee, Ming-Sun Yu, Wen-Li Hwang, Pang-Yu Lai, Cheng-Shyong Chang, Wen-Chi Chou, Ruey-Kuen Hsieh. Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan. Journal of Pain and Symptom Management. 2017, 54 (1):55-65 el
    78. Johnson Lin, Ruey-Kuen Hsieh, Jen-Shi Chen, Kuan-Der Lee, Kun-Ming Rau, Yu-Yun Shao, Yung-Chuan Sung, Su-Peng Yeh, Cheng-Shyong Chang, Ta-Chih Liu, Ming-Fang Wu, Ming-Yang Lee, Ming-Sun Yu, Chia-Jui Yen, Pang-Yu Lai, Wen-Li Hwang, Tzeon-Jye Chiou. Satisfaction with pain management and impact of pain on quality of life in cancer patients. Asia-Pacific Journal of Clinical Oncology. 17 Oct. 2018. https://doi.org/10.1111/ajco.13095
    79. Shang-Hung Chen, Hsiang-Lin, Jeng-Kai Jiang, Yung-Chuan Sung, Ching-Wen Huang, Yu-Min Yeh, Li-Tzong Chen, Jaw-Yuan Wang. Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol. BMC Cancer (2019) 19:640. https://doi.org/10.1186/s12885-019-5826-7
    80. Shih-Feng Cho, Kun-Ming Rau, Yu-Yun Shao, Chia-Jui Yen, Ming-Fang Wu, Jen-Shi Chen, Cheng-Shyong Chang, Su-Peng Yeh, Tzeon-Jye Chiou, Ruey-Kuen Hsieh, Ming-Yang Lee, Yung-Chuan Sung, Kuan-Der Lee Pang-Yu Lai, Ming-Sun Yu, Wen-Li Hwang, Ta-Chih Liu. Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study. Supportive Care in Cancer (2019) 27:1663-1672. https://doi.org/10.1007/s00520-018-4404-x
    81. Wen-Chi Chou, Jen-Shi Chen, Chia-Yen Hung, Chang-Hsieh Lu, Yu-Yun Shao, Tzeon-Jye Chiou, Yung-Chuan Sung, Kun-Ming Rau, Jia-Jui Yen, Su-Peng Yeh, Ta-Chih Liu, Ming-Fang Wu, Ming-Yang Lee, Ming-Sun Yu, Wen-Li Hwang, Pang-Yu Lai, Cheng-Shyong Chang, Ruey-Kuen Hsieh. A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life. Supportive Care in Cancer (2019) 27:2857-2867. https://doi.org/10.1007/s00520-018-4599-x
    82. Jiin-Torng Wu, Ching-Ling Lin, Chi-Jung Huang, Yu-Che Cheng, Chih-Cheng Chien, Yung-Chuan Sung. Potential synergistic effects of sorafenib and CP-31398 for treating anaplastic thyroid cancer with p53 mutations. Oncology Letters 2020, 19:3021-3026. https://doi:10.3892/ol.2020.11377
    83. Che-Pin Lin, Yung-Chuan Sung, Cheng-Yu Lo, Ming-Hong Yen. Pathological complete response of initially inoperable lung squamous cell carcinoma treated by immunochemotherapy: A case report. Asian J Surg. 2020 Jan; 43 (1): 393-395. Doi: 10.1016/j.asjsur.2019.10.008 .Epub 2019 Nov 11.
    84. Hsiang-Lin Tsai, Ching-Wen Huang, Yi-Wen Lin, Jui-Ho Wang, Chang-Chieh Wu, Yung-Chuan Sung, Tzu-Liang Chen, Hwei-Ming Wang, Hsiu-Chin Tang, Joe-Bin Chen, Tao-Wei Ke, Chang-Sung Tsai, Hsuan-Yuan Huang, Jaw-Yuan Wang. Determination of the UGT1A1 polymorphism as guidance for irinotecan dose escalation in metastatic colorectal cancer treated with first-line bevacizumab and FOLFIRI (PURE FIST). European Journal of Cancer 138 (2020): 19-29
    85. Che-Pin Lin, Yung-Chuan Sung, Jia-Uei Wong. Immunotherapy improves efficiency of conversion surgery for metastatic gastric cancer: A case report. Asian J Surg. 2020 Jul 28;S1015-9584(20)31-9. Doi: 10.1016/j.asjsur.2020.06.016.
    86. Chin-Fu Weng, Chi-Jung Huang, Shih-Hung Huang, Mei-Hsuan Wu, Ailun Heather Tseng, Yung-Chuan Sung, Henry Hsin-Chung Lee, Thai-Yen Ling. New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma. Cancers 2020. 12(11), 3426. http://doi.org/10.3390/cancers12113426 - 18 Nov 2020

    Poster

    1. 洪志桓,林素玲,陳怡君,黃金山,宋詠娟,林思源 Orbital Osteoblastic Osteosarcoma-A Case Report 2009/4/25 中華民國眼科醫學會學術研討會
    2. 宋詠娟,施盈逸,劉漢鼎 單一機構之轉移性結腸直腸癌病人手術合併化學及標靶治療之經驗 第14th屆 (2009) 台灣癌症學術年會
    3. Yung-Chuan Sung, Chi-Lan Kao,, Rong-Maw Liu, Han-Tin Liu, Chung-King Lin, Hui-Wen Liu. Preventing Chemotherapy Prescription Errors by Using CPOE—Experience of a Medical Center 第15th屆 (2010) 台灣癌症學術年會
    4. Hui-Wen Liu, Yung-Chuan Sung, Han-Ting Liu, Chung-King Lin, Yingyih Shih. UGT1A1 Used to Predict Hematology Toxicities of Irinotecan: Experience of Cathay General Hospital. 第16th屆 (2011) 台灣癌症學術年會
    5. Hui-Wen Liu, Yung-Chuan Sung, Han-Ting Liu, Chung-King Lin, Yingyih Shih. UGT1A1 Used to Predict Hematology Toxicities of Irinotecan: Experience of Cathay General Hospital. 9th Asia Pacific Oncology Summit; Scanning the Therapeutic Horizon: Optimal Care, Individual Focus. Patient Managemnet: Winner. (2011/9)
    6. Chung-King Lin, Ling-Ping Chen, Hsiu-Lin Chang, Yung-Chuan Sung. Underestimation of the coexistence of iron deficiencies and thalassemia minors: a single institution experience in Taiwan第27屆台灣內科醫學會
    7. Tzeon-Jye Chiou, Tsai-Yun Chen, Yii-Jeng Lan, Syuan-Yu Lin, Li-Yuan Bai, Yi-Fang Chang, Yung-Chuan Sung, Wen-Li Huang, Erh-Jung Hsueh, Sheng-Feng Lin, Ming-Chung Wang, Caleb Gonshen Chen. Expanded Access Program for Eltrombopag in the Treatment of Patients with Chronic Refractory Idiopathic Thrombocytopenic Purpura (ITP) in Taiwan: A Preliminary Analysis. 5th International Hematologic Malignancies Conference, Bridging the Gap 2014
    8. Ling-Ping Chen, Ying-Yih Shih, Yuan-Hsin Chang, Hui-Wen Liu, Yung-Chuan Sung. UGT1A1*28 polymorphisms in Clinical practice of Metastatic Colorectal Cancer. The 20th TJCC, T7-58
    9. Ling-Ping Chen, Ying-Yih Shih, Yuan-Hsin Chang, Hui-Wen Liu, Yung-Chuan Sung. Genotype get and Experience with Target Therapy in Metastatic Colorectal Cancer. The 20th TJCC, T7-57
    10. Ling-Ping Chen, Ying-Yih Shih, Yuan-Hsin Chang, Hui-Wen Liu, Yung-Chuan Sung.Cancer Guideline adherence Rate and Implementing an Electronic Health Record System in Survivorship Care Planning. The 20th TJCC, T7-60
    11. Ruey-Kuen Hsieh, Shiow-Ching Shun, Kun-Ming Rau, Tzeon-Jye Chiou, Yung-Chuan Sung, Su-Peng Yeh.Occurrence, severity and impact of cancer-related fatigue in Taiwanese cancer patients: A national survey. 2015 Palliative Care in Oncology Symposium, Boston, Abst. # 155471
    12. Emergence of RAS mutation in RAS wild type mCRC patients receiving Cetuximab as first-line treatment: a non-interventional uncontrolled multi center study. Hsiang-Lin Tsai, Jenn-Kai Jiang, Yung-Chuan Sung, Shang-Hung Chen, and Jaw-Yuan Wang. ASCO GI 2023. No.#38

 


更新時間:2023/4/25